Oragenics names new CEO, shares rise
24/06/2022 17:14
** Shares of biotech company Oragenics Inc OGEN.A rise as
much as 8.1% to 32 cents
** Co late on Thursday named industry veteran Kimberly
Murphy as president and chief executive officer, effective June
23 urn:newsml:reuters.com:*:nBw2prf3da
** Murphy, who joined the OGEN board in 2020, brings more
than 25 years of vaccine industry experience at leading
pharmaceutical companies
** Stock down ~29% YTD, as of last close
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com; Twitter: https://twitter.com/rithika_krishna;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing